| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.703 | 16.405 | 40.797 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.759 | 16.405 | 40.798 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.056 | 15.022 | 40.437 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.703 | 1.384 | 361 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.534 | 994 | 18 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Ad Lotus Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 886 | 877 | 862 | 846 | 830 | 814 | 796 | 4.050 | 4.038 | 4.543 |
| Current Assets | 623 | 626 | 616 | 604 | 593 | 582 | 569 | 2.209 | 7.189 | 14.161 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99 | 217 |
| Receivables | 633 | 626 | 616 | 604 | 593 | 582 | 569 | 310 | 1.644 | 10.644 |
| Cash | -9 | 0 | 0 | 0 | 0 | 0 | 0 | 1.899 | 5.446 | 3.301 |
| Shareholders Funds | -8.896 | -8.805 | -8.656 | -8.497 | -8.332 | -8.175 | -7.993 | 4.110 | 5.092 | 5.082 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.405 | 10.308 | 10.134 | 9.948 | 9.755 | 9.570 | 9.358 | 2.149 | 6.135 | 13.622 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Ad Lotus Therapy S.r.l.